Ameritas Investment Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.9M | Buy |
49,963
+865
| +2% | +$192K | 0.33% | 46 |
|
|
2025
Q4 | $11.2M | Sell |
49,098
-1,670
| -3% | -$380K | 0.34% | 44 |
|
|
2025
Q3 | $11.8M | Sell |
50,768
-2,056
| -4% | -$419K | 0.36% | 37 |
|
|
2025
Q2 | $9.8M | Sell |
52,824
-451
| -0.8% | -$83.8K | 0.31% | 45 |
|
|
2025
Q1 | $11.2M | Sell |
53,275
-1,435
| -3% | -$279K | 0.38% | 35 |
|
|
2024
Q4 | $9.72M | Sell |
54,710
-617
| -1% | -$113K | 0.32% | 40 |
|
|
2024
Q3 | $10.9M | Sell |
55,327
-2,761
| -5% | -$515K | 0.36% | 38 |
|
|
2024
Q2 | $9.96M | Sell |
58,088
-36
| -0.1% | -$5.96K | 0.34% | 39 |
|
|
2024
Q1 | $10.6M | Sell |
58,124
-4,072
| -7% | -$702K | 0.36% | 37 |
|
|
2023
Q4 | $9.64M | Buy |
62,196
+5,681
| +10% | +$828K | 0.35% | 37 |
|
|
2023
Q3 | $8.42M | Buy |
56,515
+5,025
| +10% | +$738K | 0.34% | 39 |
|
|
2023
Q2 | $6.94M | Buy |
51,490
+5,573
| +12% | +$817K | 0.26% | 48 |
|
|
2023
Q1 | $7.32M | Buy |
45,917
+456
| +1% | +$69.7K | 0.29% | 46 |
|
|
2022
Q4 | $7.07M | Buy |
45,461
+10,442
| +30% | +$1.6M | 0.28% | 48 |
|
|
2022
Q3 | $4.7M | Buy |
35,019
+347
| +1% | +$49.8K | 0.21% | 76 |
|
|
2022
Q2 | $5.31M | Sell |
34,672
-413
| -1% | -$63.1K | 0.23% | 64 |
|
|
2022
Q1 | $5.69M | Sell |
35,085
-3,188
| -8% | -$463K | 0.2% | 73 |
|
|
2021
Q4 | $5.18M | Buy |
38,273
+1,071
| +3% | +$127K | 0.17% | 90 |
|
|
2021
Q3 | $4.01M | Sell |
37,202
-302
| -0.8% | -$34.5K | 0.15% | 108 |
|
|
2021
Q2 | $4.22M | Buy |
37,504
+974
| +3% | +$110K | 0.15% | 101 |
|
|
2021
Q1 | $3.94M | Sell |
36,530
-1,402
| -4% | -$150K | 0.15% | 107 |
|
|
2020
Q4 | $4.06M | Buy |
37,932
+5,204
| +16% | +$500K | 0.19% | 92 |
|
|
2020
Q3 | $2.87M | Sell |
32,728
-1,910
| -6% | -$180K | 0.13% | 149 |
|
|
2020
Q2 | $3.4M | Sell |
34,638
-373
| -1% | -$32.8K | 0.16% | 99 |
|
|
2020
Q1 | $2.67M | Sell |
35,011
-496
| -1% | -$42.2K | 0.15% | 111 |
|
|
2019
Q4 | $3.14M | Sell |
35,507
-8,655
| -20% | -$719K | 0.14% | 129 |
|
|
2019
Q3 | $3.34M | Sell |
44,162
-20,853
| -32% | -$1.43M | 0.15% | 119 |
|
|
2019
Q2 | $4.73M | Sell |
65,015
-216
| -0.3% | -$17K | 0.22% | 68 |
|
|
2019
Q1 | $5.26M | Sell |
65,231
-1,307
| -2% | -$107K | 0.24% | 58 |
|
|
2018
Q4 | $6.13M | Sell |
66,538
-594
| -0.9% | -$52.2K | 0.33% | 42 |
|
|
2018
Q3 | $6.35M | Sell |
67,132
-742
| -1% | -$70.4K | 0.29% | 46 |
|
|
2018
Q2 | $6.29M | Buy |
67,874
+6,807
| +11% | +$665K | 0.3% | 41 |
|
|
2018
Q1 | $5.78M | Buy |
61,067
+17,532
| +40% | +$1.93M | 0.28% | 42 |
|
|
2017
Q4 | $4.18M | Buy |
43,535
+2,073
| +5% | +$195K | 0.19% | 89 |
|
|
2017
Q3 | $3.19M | Buy |
41,462
+140
| +0.3% | +$10.7K | 0.15% | 123 |
|
|
2017
Q2 | $3M | Buy |
41,322
+601
| +1% | +$40.4K | 0.15% | 135 |
|
|
2017
Q1 | $2.65M | Sell |
40,721
-1,238
| -3% | -$77.8K | 0.13% | 157 |
|
|
2016
Q4 | $2.63M | Buy |
41,959
+340
| +0.8% | +$20.8K | 0.13% | 167 |
|
|
2016
Q3 | $2.63M | Buy |
41,619
+9,360
| +29% | +$606K | 0.14% | 141 |
|
|
2016
Q2 | $2M | Buy |
32,259
+74
| +0.2% | +$4.51K | 0.13% | 171 |
|
|
2016
Q1 | $1.84M | Buy |
32,185
+120
| +0.4% | +$6.69K | 0.12% | 180 |
|
|
2015
Q4 | $1.9M | Sell |
32,065
-441
| -1% | -$25.4K | 0.13% | 173 |
|
|
2015
Q3 | $1.77M | Sell |
32,506
-1,137
| -3% | -$74K | 0.13% | 186 |
|
|
2015
Q2 | $2.26M | Buy |
33,643
+2,478
| +8% | +$162K | 0.15% | 159 |
|
|
2015
Q1 | $1.82M | Hold |
31,165
| – | – | 0.12% | 192 |
|
|
2014
Q4 | $2.04M | Buy |
31,165
+1,832
| +6% | +$115K | 0.14% | 159 |
|
|
2014
Q3 | $1.69M | Sell |
29,333
-1,748
| -6% | -$97K | 0.12% | 194 |
|
|
2014
Q2 | $1.75M | Sell |
31,081
-310
| -1% | -$16.3K | 0.13% | 186 |
|
|
2014
Q1 | $1.61M | Sell |
31,391
-2,003
| -6% | -$101K | 0.13% | 199 |
|
|
2013
Q4 | $1.76M | Sell |
33,394
-162
| -0.5% | -$7.96K | 0.14% | 193 |
|
|
2013
Q3 | $1.5M | Buy |
+33,556
| New | +$1.49M | 0.14% | 193 |
|
Other funds holding ABBV
VCM
VPM
Ameritas Investment Partners's ABBV Position: Q1 2026 in Review
Ameritas Investment Partners increased its AbbVie (ABBV) stake by 1.8% in Q1 2026, buying an estimated $192K and bringing the position to 49,963 shares worth $10.9M. The position accounts for 0.33% of the portfolio, ranked #46.
Ameritas Investment Partners first reported a position in ABBV in Q3 2013 and has held it in 51 quarters since. The position peaked at $11.8M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Ameritas Investment Partners held 49,963 shares of AbbVie worth $10.9M as of Q1 2026.
- Ameritas Investment Partners bought 865 AbbVie shares in Q1 2026, an estimated $192K.
- AbbVie made up 0.33% of Ameritas Investment Partners's portfolio in Q1 2026, its #46 holding.
- Ameritas Investment Partners first reported a position in AbbVie in Q3 2013 and has held it in 51 quarters since.
- Ameritas Investment Partners's AbbVie position peaked at $11.8M in Q3 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.